BHARATHAN, INDU T.,BLACKBURN, CHRIS,CIAVARRI, JEFFREY P.,CHOUITAR, JOUHARA,CULLIS, COURTNEY A.,DAMORE, NATALIE,FLEMING, PAUL E.,GIGSTAD, KENNETH M.,GIPSON, KRISTA E.,GIRARD, MARIO,HU, YONGBO,LEE, JANI
申请号:
SG11201604820X
公开号:
SG11201604820XA
申请日:
2015.01.13
申请国别(地区):
SG
年份:
2016
代理人:
摘要:
and pharmaceutically acceptable salts thereof, wherein X, R1, R2, R3, R4, R5, L1, L2, m, and n, are as described in the specification. Such compounds are inhibitors of VPS34 and thus useful for treating proliferative, inflammatory, or cardiovascular disorders.